May 21, 2020 / 12:23 AM / 7 days ago

BRIEF-Biotricity Received Communication From FDA Stating Bioflux Software Device is in Substantiative Phase

May 20 (Reuters) - Biotricity Inc:

* BIOTRICITY FDA SUBMISSION UPDATE

* RECEIVED COMMUNICATION FROM FDA STATING BIOFLUX SOFTWARE DEVICE IS NOW IN SUBSTANTIATIVE PHASE OF REVIEW PROCESS

* EXPECTS FDA RESPONSE BY END OF JUNE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below